78 related articles for article (PubMed ID: 26105696)
1. Lower serum soluble-EGFR is a potential biomarker for metastasis of HCC demonstrated by N-glycoproteomic analysis.
Hu H; Gao L; Wang C; Li Y; Ma H; Chen L; Qin J; Liu B; Liu Y; Liang C
Discov Med; 2015 May; 19(106):333-41. PubMed ID: 26105696
[TBL] [Abstract][Full Text] [Related]
2. Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.
Wang C; Guo K; Gao D; Kang X; Jiang K; Li Y; Sun L; Zhang S; Sun C; Liu X; Wu W; Yang P; Liu Y
Cancer Lett; 2011 Dec; 313(2):154-66. PubMed ID: 22023829
[TBL] [Abstract][Full Text] [Related]
3. LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway.
Wang X; Zhang W; Tang J; Huang R; Li J; Xu D; Xie Y; Jiang R; Deng L; Zhang X; Chai Y; Qin X; Sun B
Cell Death Dis; 2016 Mar; 7(3):e2130. PubMed ID: 26938303
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.
Wang C; Jiang K; Kang X; Gao D; Sun C; Li Y; Sun L; Zhang S; Liu X; Wu W; Yang P; Guo K; Liu Y
Int J Biochem Cell Biol; 2012 Dec; 44(12):2308-20. PubMed ID: 23010347
[TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma.
Qi YJ; Ward DG; Pang C; Wang QM; Wei W; Ma J; Zhang J; Lou Q; Shimwell NJ; Martin A; Wong N; Chao WX; Wang M; Ma YF; Johnson PJ
Proteomics; 2014 Feb; 14(2-3):186-95. PubMed ID: 24259486
[TBL] [Abstract][Full Text] [Related]
6. Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles.
Wang FB; Rong Y; Fang M; Yuan JP; Peng CW; Liu SP; Li Y
Biomaterials; 2013 May; 34(15):3816-27. PubMed ID: 23465488
[TBL] [Abstract][Full Text] [Related]
7. Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer.
Lococo F; Paci M; Rapicetta C; Rossi T; Sancisi V; Braglia L; Cavuto S; Bisagni A; Bongarzone I; Noonan DM; Albini A; Maramotti S
Int J Mol Sci; 2015 Aug; 16(8):19612-30. PubMed ID: 26295387
[TBL] [Abstract][Full Text] [Related]
8. [Experimental observation on the alteration of metastatic potential and its gene function net of residual hepatocellular carcinoma following palliative liver resection].
Huang XY; Huang ZL; Tang ZY; Xu B; Zheng Q; Zhou J; Wang L; Ye SL
Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1278-82. PubMed ID: 20646604
[TBL] [Abstract][Full Text] [Related]
9. High-throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular carcinoma by iTRAQ combines lectin-related techniques.
Qin X; Chen Q; Sun C; Wang C; Peng Q; Xie L; Liu Y; Li S
Med Oncol; 2013 Mar; 30(1):420. PubMed ID: 23292873
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional profiling of glycogenes associated with hepatocellular carcinoma metastasis.
Liu T; Zhang S; Chen J; Jiang K; Zhang Q; Guo K; Liu Y
PLoS One; 2014; 9(9):e107941. PubMed ID: 25232831
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.
Tse EY; Ko FC; Tung EK; Chan LK; Lee TK; Ngan ES; Man K; Wong AS; Ng IO; Yam JW
J Pathol; 2012 Mar; 226(4):645-53. PubMed ID: 22072235
[TBL] [Abstract][Full Text] [Related]
13. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
[TBL] [Abstract][Full Text] [Related]
16. Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
Zhang P; Chan DW; Zhu Y; Li JJ; Ng IO; Wan D; Gu J
Clin Cancer Res; 2006 Nov; 12(22):6617-25. PubMed ID: 17121880
[TBL] [Abstract][Full Text] [Related]
17. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma.
Wu X; Jia HL; Wang YF; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
Oncogene; 2006 Mar; 25(12):1832-40. PubMed ID: 16261160
[TBL] [Abstract][Full Text] [Related]
18. Tiam1 is associated with hepatocellular carcinoma metastasis.
Huang J; Ye X; Guan J; Chen B; Li Q; Zheng X; Liu L; Wang S; Ding Y; Ding Y; Chen L
Int J Cancer; 2013 Jan; 132(1):90-100. PubMed ID: 22573407
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells.
Blivet-Van Eggelpoël MJ; Chettouh H; Fartoux L; Aoudjehane L; Barbu V; Rey C; Priam S; Housset C; Rosmorduc O; Desbois-Mouthon C
J Hepatol; 2012 Jul; 57(1):108-15. PubMed ID: 22414764
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]